PRMT1 and cancer: To this end, we generated a mouse cancer cell line CT26 that stably expressed a DOX-inducible shPrmt1 construct (hereafter CT26-tet-on-shPrmt1), which proceeded to RNA-sequencing to analyze PRMT1-responsive genes (Fig. 4b).